RGS22 Activators
Compounds like Forskolin, and Y-27632 play critical roles in modulating GPCR signaling pathways. Forskolin, by increasing cAMP levels, and GTPγS, as a GTP analog, can affect the functional dynamics of G-proteins, which are crucial for RGS22 activity. Y-27632's effect on Rho-associated protein kinases can also influence GPCR signaling, thereby affecting RGS22's regulatory role.
Propranolol, modulate different aspects of GPCR signaling pathways. U73122's inhibition of phospholipase C and Pertussis Toxin's effect on Gi/o type G-proteins can alter GPCR-mediated signaling, enhancing the regulatory function of RGS22. Propranolol and Isoproterenol, through their antagonist and agonist roles on beta-adrenergic receptors, respectively, demonstrate the influence of GPCR ligands on the signaling pathways where RGS22 may be involved. Additionally, compounds like Sildenafil, Carbachol, LPA, NGF, and PDGF highlight the diverse mechanisms through which GPCR signaling can be modulated, impacting RGS22's activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in cAMP, which can enhance GPCR signaling pathways where RGS22 may be involved. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632, a Rho-associated protein kinase inhibitor, can influence GPCR signaling pathways, potentially enhancing RGS22 activity in these pathways. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol, a beta-adrenergic receptor antagonist, can modulate GPCR signaling pathways, potentially affecting RGS22's activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic receptor agonist, can activate GPCR signaling pathways where RGS22 may play a regulatory role. | ||||||
Carbachol | 51-83-2 | sc-202092 sc-202092A sc-202092C sc-202092D sc-202092B sc-202092E | 1 g 10 g 25 g 50 g 100 g 250 g | $122.00 $281.00 $388.00 $683.00 $1428.00 $3060.00 | 12 | |
Carbachol, a cholinergic agonist, activates GPCRs and can modulate signaling pathways where RGS22 is involved. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA activates GPCR signaling pathways, potentially enhancing RGS22's regulatory role in these pathways. | ||||||